Items where Funder is Newlife Charity for Disabled Children.

12-13/11

Smith, C. E. L., Streets, A. J., Lake, A. V. R. et al. (14 more authors) (2025) Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies. Communications Medicine, 5. 129. ISSN 2730-664X

Smith, CEL orcid.org/0000-0001-8320-5105, Lake, AVR and Johnson, CA orcid.org/0000-0002-2979-8234 (2020) Primary Cilia, Ciliogenesis and the Actin Cytoskeleton: A Little Less Resorption, A Little More Actin Please. Frontiers in Cell and Developmental Biology, 8. 622822. ISSN 2296-634X

BB/P007791/1

Smith, C. E. L., Streets, A. J., Lake, A. V. R. et al. (14 more authors) (2025) Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies. Communications Medicine, 5. 129. ISSN 2730-664X

Smith, CEL orcid.org/0000-0001-8320-5105, Lake, AVR and Johnson, CA orcid.org/0000-0002-2979-8234 (2020) Primary Cilia, Ciliogenesis and the Actin Cytoskeleton: A Little Less Resorption, A Little More Actin Please. Frontiers in Cell and Developmental Biology, 8. 622822. ISSN 2296-634X

GN2628

Smith, C. E. L., Streets, A. J., Lake, A. V. R. et al. (14 more authors) (2025) Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies. Communications Medicine, 5. 129. ISSN 2730-664X

Smith, CEL orcid.org/0000-0001-8320-5105, Lake, AVR and Johnson, CA orcid.org/0000-0002-2979-8234 (2020) Primary Cilia, Ciliogenesis and the Actin Cytoskeleton: A Little Less Resorption, A Little More Actin Please. Frontiers in Cell and Developmental Biology, 8. 622822. ISSN 2296-634X

HEALTH-F5-2010-241955

Smith, C. E. L., Streets, A. J., Lake, A. V. R. et al. (14 more authors) (2025) Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies. Communications Medicine, 5. 129. ISSN 2730-664X

PKD_RP_006_20211124

Smith, C. E. L., Streets, A. J., Lake, A. V. R. et al. (14 more authors) (2025) Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies. Communications Medicine, 5. 129. ISSN 2730-664X